Jazz Pharmaceuticals plc
JAZZ
$244.96
-$0.89-0.36%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -34.22% | 44.06% | -19.08% | 134.99% | -676.76% |
| Total Depreciation and Amortization | -1.27% | 1.25% | 0.52% | 2.44% | 5.58% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 354.98% | -202.97% | 161.28% | -108.94% | 1,277.76% |
| Change in Net Operating Assets | -680.17% | 83.37% | -155.59% | 140.02% | -213.62% |
| Cash from Operations | 1.84% | 12.60% | -23.62% | 434.48% | -79.34% |
| Capital Expenditure | 8.12% | -17.76% | -10.24% | -17.64% | 7.19% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 100.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 161.20% | 137.23% | -22.70% | -235.92% | 248.29% |
| Cash from Investing | 188.30% | 133.08% | -13.53% | 48.86% | -279.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -12,819.23% | -0.65% | 0.00% | -0.65% | 98.98% |
| Issuance of Common Stock | -31.00% | -61.38% | 11,521.56% | -93.02% | -8.70% |
| Repurchase of Common Stock | 90.83% | -5,090.38% | 47.64% | 97.00% | -89.29% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1,166.88% | -204.06% | 796.65% | 91.30% | 84.71% |
| Foreign Exchange rate Adjustments | -50.00% | -1,312.12% | -83.74% | -95.59% | 170.59% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -149.62% | 587.24% | -51.66% | 120.27% | -21.96% |